HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y Kerneis Selected Research

LNH 87 protocol

3/2001Pathologic and clinical features of 77 Hodgkin's lymphoma patients treated in a lymphoma protocol (LNH87): a GELA study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y Kerneis Research Topics

Disease

2Hodgkin Disease (Hodgkin's Disease)
08/2001 - 03/2001
1Sclerosis
08/2001
1Lymphoma (Lymphomas)
03/2001
1Non-Hodgkin Lymphoma (Lymphosarcoma)
03/2001
1Neoplasms (Cancer)
08/2000
1Leukemia
08/2000

Drug/Important Bio-Agent (IBA)

1N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA
08/2001
1Topoisomerase II InhibitorsIBA
08/2000

Therapy/Procedure

1Drug Therapy (Chemotherapy)
08/2001
1LNH 87 protocol
03/2001
1Stem Cell Transplantation
08/2000